OpinionBlackstone bets a billion on PTC Therapeutics; Grant Ave brings in Brian Berkin for healthcare expertiseBlackstone inks deal with PTC Therapeutics.Aaron Weitzman - 28 October 2022 Share A- A+ 100% Create an account to continue reading Gain instant access to our expert editorial analysis and in-depth insight. Register for free Already have an account? Sign in